http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
$3,500,000 Initial Order for FDA-Registered, Premium Hand Sanitizer Catapults SkinScience Labs, a Pending Accretive Acquisition of Pressure BioSciences, Into the Multi-Billion Dollar Hand Sanitizer Ma
-
Pressure BioSciences Announces First Manufacturing Build Completely Sold Out for Revolutionary UST System for Processing Hemp-Derived Cannabinoid Oil into Stable, Water-Soluble Nanoemulsions
-
Pressure BioSciences Announces Launch of Novel, FDA Registered Immune Booster by Pending Merger Partner Cannaworx, Inc.
-
Pressure BioSciences Pending Merger Partner Cannaworx, Inc. Announces Letter of Intent to Acquire Five Leaf Labs, Delivering Major Expansion of Sales and Distribution Network
-
Pressure BioSciences Announces Launch of FDA-Registered Hand Sanitizer as First Product Developed Through Pending Merger Partners
-
Former L'Oréal President Jim Morrison Appointed as CEO To Lead Availa Bio Upon Merger of Pressure BioSciences, Cannaworx and SkinScience Labs
-
Pressure BioSciences Announces Planned Name Change to "Availa Bio" Following Completion of Cannaworx and SkinScience Labs Transactions
-
Pressure BioSciences, Through Cannaworx, Inc., Announces Letter of Intent to Acquire SkinScience Labs, Inc.
-
Pressure BioSciences Announces Plans to Acquire Cannaworx, Inc.
-
Pressure BioSciences and RedShiftBio Demonstrate Potential of Combining Proprietary Technologies to Enable New Tool for Development and Production of Biotherapeutics
-
Pressure BioSciences Nearing Complete Sellout on Pre-launch Offering of Game-Changing UST System for Processing CBD Oil Into Water-soluble Nanoemulsions
-
Pressure BioSciences Launches New Era in Preparation of Water-Soluble Nanoemulsions, for CBD and Other Valuable Oils, with Opening of UST Demonstration Laboratory
-
Pressure BioSciences Launches New Era in Preparation of Water-Soluble Nanoemulsions, for CBD and Other Valuable Oils, With Opening of UST Demonstration Laboratory
-
Zacks Small Cap Research Releases Updated Report on Pressure BioSciences, Inc.
-
Pressure BioSciences Accelerating Rollout of Proprietary UST Platform for Water-Soluble CBD with Planned Release of Additional BaroShear Instrument
-
Pressure BioSciences Announces Significant New Order and Near Sellout on Revolutionary Nanoemulsification System for Water-Soluble CBD Oil
-
Zacks Small Cap Research Releases Updated Report on Pressure BioSciences, Inc.
-
Pressure BioSciences, Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update
-
Pressure BioSciences, Inc. to Discuss Third Quarter 2019 Financial Results and Provide Business Update
-
Zacks Small Cap Research Initiates Coverage on Pressure BioSciences, Inc.
-
Pressure BioSciences’ Proprietary PCT Platform Fills Pivotal Role for Tumor Analyses in Novel Workflow Presented at Leading Global Gynecologic Cancer Meeting
-
Pressure BioSciences’ PCT Platform Featured in Multiple Presentations at Major International Science Conference
-
Pressure BioSciences Prepares for Growth, Adding Daniel J. Shea as Chief Financial Officer
-
Pressure BioSciences’ PCT Platform Identified as Pivotal for Cancer Biomarker Discovery and for Potential Clinical Diagnostics
-
Pressure BioSciences Announces Two More Purchase Orders for its Revolutionary BaroShear K45 Processing System for Manufacturing Water-Soluble CBD
-
Pressure BioSciences, Inc. Reports Second Quarter 2019 Financial Results and Provides Business Update
-
Pressure BioSciences Announces First Close and Customer for its Revolutionary Water-Soluble CBD Manufacturing System, the BaroShear K45
-
Pressure BioSciences Announces Second Major Contract Utilizing its BaroFold Protein Refolding and Disaggregation Biopharma Services
-
Pressure BioSciences' PCT Platform Highlighted at International Conference in China
-
Pressure BioSciences Enters CBD Market with Launch of Novel Instrument System to Revolutionize Manufacturing of High Quality, Water-Soluble CBD
-
Pressure BioSciences Announces Achievement of First Major Milestone in Development of Potential Breakthrough Processing Method for Higher Quality and Safer Food and Beverages
-
Pressure BioSciences' Ultra High Pressure HUB Platform Highly Effective in Studies to Develop Improved Methods for Food Safety
-
Pressure BioSciences' PCT Platform Prominently Featured in Record Number of Presentations at Major International Science Conference
-
Pressure BioSciences, Inc. Reports First Quarter 2019 Financial Results and Provides Business Update
-
Pressure BioSciences, Inc. to Discuss First Quarter 2019 Financial Results and Provide Business Update
-
Pressure BioSciences Announces CEO Succession Plan
-
Pressure BioSciences, Inc. Reports Record Fourth Quarter and Fiscal Year 2018 Financial Results and Provides Business Update
-
Pressure BioSciences, Inc. to Discuss Fourth Quarter and Fiscal Year 2018 Financial Results and Provide Business Update
-
Pressure BioSciences and The Steinbeis Centre Combine Efforts to Develop Revolutionary Method Based on Optimizing Disease-Fighting Antibodies
-
Uptick Newswire Hosts Pressure BioSciences, Inc. on the Stock Day Podcast to Discuss Their (1) Just Announced Collaboration With NutraFuels, Inc., (2) the Commercial Launch of Their BioPharmaceuticals
-
Pressure BioSciences, Inc and NutraFuels, Inc to Collaborate on the Development of Water-Soluble Nanoemulsion-based Nutraceuticals
-
Record Number of Scientific Papers Citing the Significant Benefits of Pressure BioSciences' PCT Platform Published in 2018
-
Pressure BioSciences, Inc. Announces Commercial Launch of its Unique Biopharmaceuticals Contract Services Business
-
Major Cancer Research Center Reports Pressure BioSciences' PCT Platform Could Play Major Role in Improving Cancer Diagnosis and Treatment
-
Pressure BioSciences, Inc. to Host Business Update on Wednesday, December 19th at 4:30 PM EST
-
Pressure BioSciences Expands on Recent Achievement of Major Development Milestones in Ultra Shear Technology for Diverse High Value Products, Including CBD Oil
-
Pressure BioSciences Achieves Second Major Milestone in the Development of Its Ultra Shear Technology Platform
-
Pressure BioSciences, Inc. Reports Third Quarter and YTD 2018 Financial Results and Provides Business Update
-
Pressure BioSciences, Inc. to Discuss Third Quarter 2018 Financial Results and Provide Business Update
-
Pressure BioSciences Achieves Major Milestone in the Development of its Ultra Shear Technology Program

